![David Bryant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Bryant
Directeur/Membre du Conseil chez
AVACTA GROUP PLC
Fortune : 145 482 $ au 30/09/2026
Profil
David Bryant currently works at Avacta Group Plc, as Independent Non-Executive Director from 2025 and Berry Capital Management LLC, as Director.
Mr. Bryant also formerly worked at Wyeth Pharmaceuticals LLC, as Commercial Director-EMEA Region, Clinigen Ltd., as Director from 2023 to 2024, Glaxo Wellcome Plc, as Principal, GSK Plc, as Principal, and GlaxoSmithKline Services Unlimited, as Business Manager.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVACTA GROUP PLC 0,03% | 06/10/2026 | 152 894 ( 0,03% ) | 145 482 $ | 30/09/2026 |
Postes actifs de David Bryant
| Sociétés | Poste | Début |
|---|---|---|
| AVACTA GROUP PLC | Directeur/Membre du Conseil | 28/05/2025 |
Berry Capital Management LLC
 Berry Capital Management LLC Investment ManagersFinance Provides investment advisory services | Directeur/Membre du Conseil | - |
Anciens postes connus de David Bryant
| Sociétés | Poste | Fin |
|---|---|---|
| CLINIGEN GROUP PLC | Directeur Général | 03/01/2023 |
GlaxoSmithKline Services Unlimited
 GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Glaxo Wellcome Plc
Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
GlaxoSmithKline Services Unlimited
GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Clinigen Ltd.
 Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical services company that engages in clinical trails, regulatory affairs, distribution and commercialization of pharma companies | Commercial Services |
Berry Capital Management LLC
Berry Capital Management LLC Investment ManagersFinance Provides investment advisory services | Finance |
